A Phase 1, Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1283 and mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18-55 Years
Research Grant
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
June 9, 2021
End Date
June 9, 2023
Administered By
Surgery, Surgical Sciences
Awarded By
Moderna Therapeutics, Inc.
Start Date
June 9, 2021
End Date
June 9, 2023